Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
5.1
21.39%
60%
—
241.70%
40%
—
5 Years
Score5.1
Net Growth21.39%
Net Trend60%
Net Income Consistency—
Rev Growth241.70%
Rev Trend40%
Revenue Consistency—
Relay Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 82M to $ 15M and net income went from -$ 52M to -$ 276M. Revenue increased in 2 of those 5 years; net income in 3.
Relay Therapeutics Inc currently holds a 5-year HDB Score of 5.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 20.07 | — |
1 Year2025-08-12 | $ 3.35 | 499.10% |
5 Years2021-08-12 | $ 33.52 | -40.13% |
All Time2020-07-16 | $ 35.05 | -42.74% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-07-16 |
|---|---|---|---|---|
| Price | $ 20.07 | $ 3.35 | $ 33.52 | $ 35.05 |
| Return | — | 499.10% | -40.13% | -42.74% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 10M | -$ 286M | $ 121M |
| 2025 | $ 15M | -$ 276M | $ 554M |
| 2024 | $ 10M | -$ 337M | $ 781M |
| 2023 | $ 25M | -$ 341M | $ 750M |
| 2022 | $ 1M | -$ 290M | $ 998M |
| 2021 | $ 3M | -$ 363M | $ 958M |
| IPO2020 | $ 82M | -$ 52M | $ 678M |
Explore beyond RLAY
You're looking at Relay Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
